Schedule 13G ownership disclosure

Orexigen Theraptcs

Security class unavailable · CUSIP: 686164302

Event date: 2016-03-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-18-001573
Form type
SC 13G
Filer
Nineteen77 Global Multi-Strategy Alpha Master Ltd
CIK
CIK 1698095
Filed
Feb 12, 2018
Reporting period
Mar 15, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub